China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Retrospective Study on Predicting Benign or Malignant Breast Nodules Based on Serum Antibody Protein Targets'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131766
Registration Time: 2026/09/06
Type: Observational study
Primary Sponsor: Sun Yat-sen University Cancer Center
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=309545
Published by HT Digital Content Services with permission from Health Daily Digest....